Thank you for visiting our poster session at ESMO-GI 2019
RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC)

Author: Yu Sunakawa1, Masato Nakamura2, Masahiro Ishizaki3, Masato Kataoka4, HironagaSatake5, Masaki Kitazono6, Hideyuki Yanagisawa7, Yasuyuki Kawamoto8, Hidekazu Kuramochi9, Hisatsugu Ohori10, Michio Nakamura11, Keita Takahashi12, Fumiyo Maeda13, Chihiro Komeno14, Masahiro Takeuchi15, Masashi Fujii16, Takayuki Yoshino17, WataruIchikawa18, and Akihito Tsuji19